Luca Guandalini

1.1k total citations
47 papers, 893 citations indexed

About

Luca Guandalini is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Luca Guandalini has authored 47 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 22 papers in Pharmacology and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Luca Guandalini's work include Cholinesterase and Neurodegenerative Diseases (17 papers), Neuroscience and Neuropharmacology Research (15 papers) and Nicotinic Acetylcholine Receptors Study (13 papers). Luca Guandalini is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (17 papers), Neuroscience and Neuropharmacology Research (15 papers) and Nicotinic Acetylcholine Receptors Study (13 papers). Luca Guandalini collaborates with scholars based in Italy, Hungary and France. Luca Guandalini's co-authors include María Novella Romanelli, Elisabetta Martini, Fulvio Gualtieri, Silvia Dei, Elisabetta Teodori, Serena Scapecchi, Roberta Pacifici, Dina Manetti, Francesco Paolo Busardò and Emilia Marchei and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Luca Guandalini

47 papers receiving 881 citations

Peers

Countries citing papers authored by Luca Guandalini

Since Specialization

Citations

This map shows the geographic impact of Luca Guandalini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Guandalini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Guandalini more than expected).

Fields of papers citing papers by Luca Guandalini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Guandalini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Guandalini. The network helps show where Luca Guandalini may publish in the future.

Co-authorship network of co-authors of Luca Guandalini

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Guandalini. A scholar is included among the top collaborators of Luca Guandalini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Guandalini. Luca Guandalini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry	Clinical Chemistry and Laboratory Medicine (CCLM)	Roberta Pacifici, Emilia Marchei et al.	103
2	Carbachol dimers as homobivalent modulators of muscarinic receptors	Biochemical Pharmacology	Rosanna Matucci, Cristina Bellucci et al.	7
3	Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235	Bioorganic & Medicinal Chemistry Letters	Luca Guandalini, Lorenzo Di Cesare Mannelli et al.	14
4	Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters	European Journal of Medicinal Chemistry	Silvia Dei, Marcella Coronnello et al.	22
5	Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring	European Journal of Medicinal Chemistry	Luca Guandalini, Manjola Balliu et al.	12
6	New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR)	Bioorganic & Medicinal Chemistry	Francesca Orlandi, Marcella Coronnello et al.	15
7	Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs	Bioorganic & Medicinal Chemistry Letters	Luca Guandalini, Elisabetta Martini et al.	7
8	Novel blockers of hyperpolarization‐activated current with isoform selectivity in recombinant cells and native tissue	British Journal of Pharmacology	Martina Del Lungo, Michele Melchiorre et al.	43
9	The new low‐toxic histone deacetylase inhibitor S‐(2) induces apoptosis in various acute myeloid leukaemia cells	Journal of Cellular and Molecular Medicine	Cristina Cellai, Manjola Balliu et al.	13
10	Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers	Bioorganic & Medicinal Chemistry	Elisabetta Martini, Carla Ghelardini et al.	9
11	Synthesis and Pharmacological Characterization of Chiral Pyrrolidinylfuran Derivatives: The Discovery of New Functionally Selective Muscarinic Agonists	Journal of Medicinal Chemistry	Serena Scapecchi, Rosanna Matucci et al.	4
12	Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators	Bioorganic & Medicinal Chemistry	Elisabetta Martini, Monica Norcini et al.	9
13	Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancers	Bioorganic & Medicinal Chemistry	Elisabetta Martini, Carla Ghelardini et al.	14
14	Central Nicotinic Receptors: Structure, Function, Ligands, and Therapeutic Potential	ChemMedChem	María Novella Romanelli, Paola Gratteri et al.	144
15	Molecular modulation of muscarinic antagonists. Synthesis and affinity profile of 2,2-diphenyl-2-ethylthio-acetic acid esters designed to probe the binding site cavity	Il Farmaco	Serena Scapecchi, Elisabetta Martini et al.	3
16	Design, synthesis and preliminary biological evaluation of zatebradine analogues as potential blockers of the hyperpolarization-activated current	Bioorganic & Medicinal Chemistry	María Novella Romanelli, Elisabetta Cerbai et al.	15
17	Design of novel nicotinic ligands through 3D database searching	Bioorganic & Medicinal Chemistry	Luca Guandalini, Elisabetta Martini et al.	12
18	Synthesis and cholinergic affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)- pyrrolidine, 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of Their iodomethylates	Bioorganic & Medicinal Chemistry	Silvia Dei, Cristina Bellucci et al.	11
19	2-Pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs	Il Farmaco	Serena Scapecchi, Cecilia Martelli et al.	5
20	Synthesis and pharmacological evaluation of some (pyridyl)cyclopropylmethyl amines and their methiodides as nicotinic receptor ligands	Il Farmaco	Luca Guandalini, Silvia Dei et al.	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact